Adar1 Capital Management, LLC
ADAR1 Capital Management, LLC, 10%, reported an open-market or private purchase at InMed Pharmaceuticals Inc. involving 984.000000 shares for an estimated $1300.75. Reported holdings after the transaction were 955493.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Oct 15, 2026
- Filing date
- Oct 15, 2026
How reported position traded is calculated
Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 954,509 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
INM price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Buy Code P
- Identifier
- 0001940272-26-000025 Common Shares
- Transaction date
- Oct 15, 2026 Filed Oct 15, 2026, 08:39 PM · 0d delay
- Shares
- 984 sh $1.32 per share
- Estimated value
- $1.30k Computed from shares × price
- Holdings after
- 955,493 sh Indirect · See Footnote
Filing signal explanations
Badges describe filing facts only — not predictions.
+20 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.
How this score is calculated
- open_market_purchase+12 points
transaction_code = P
Code P is a discretionary open-market purchase. - ten_percent_owner_buy+4 points
is_ten_percent_owner = true
10% beneficial owner open-market purchase. - timely_filing+4 points
reporting_delay_days = 0
Filing reported within two business days of the transaction.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
No officer title
- F1
The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.3200 to $1.3300, inclusive. Each Reporting Person undertakes to provide t…
- F2
The reported securities are owned directly by private investment funds managed by ADAR1 Capital Management, LLC, and may be deemed to be indirectly beneficially owned by (i) ADAR1 Capital Management,…
- F3
For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its pecuniary in…
0 other transactions
0 recent txs